Stock YI 111, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials 111, Inc.

Equities

YI

US68247Q1022

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.03 USD +1.98% Intraday chart for 111, Inc. +0.98% -33.55%
Apr. 25 Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading MT
Apr. 18 Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization 1 3,442 3,826 3,735 1,842 1,735
Enterprise Value (EV) 1 2,336 3,453 2,575 1,536 1,350
P/E ratio -5.52 x -7.67 x -8.18 x -2.75 x -4.16 x
Yield - - - - -
Capitalization / Revenue 1.93 x 0.97 x 0.46 x 0.15 x 0.13 x
EV / Revenue 1.31 x 0.87 x 0.31 x 0.12 x 0.1 x
EV / EBITDA -5.99 x -7.17 x -5.61 x -2.5 x -4.09 x
EV / FCF -10.6 x -7.48 x 124 x -3.24 x 12.7 x
FCF Yield -9.43% -13.4% 0.81% -30.9% 7.85%
Price to Book 2.81 x 4.95 x 10.5 x -10.7 x -4.2 x
Nbr of stocks (in thousands) 81,544 81,659 82,359 82,873 83,272
Reference price 2 42.21 46.85 45.35 22.23 20.83
Announcement Date 4/10/19 4/16/20 4/30/21 4/29/22 4/28/23
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 959.5 1,786 3,952 8,203 12,426 13,517
EBITDA 1 -239.8 -389.7 -481.8 -459.3 -614.9 -330.2
EBIT 1 -254 -400.4 -493.5 -473.3 -642.1 -371
Operating Margin -26.47% -22.42% -12.49% -5.77% -5.17% -2.74%
Earnings before Tax (EBT) 1 -249.3 -382 -501.8 -467.1 -621 -376.1
Net income 1 -248.6 -380.1 -499.6 -456.5 -669.8 -416.9
Net margin -25.91% -21.28% -12.64% -5.57% -5.39% -3.08%
EPS 2 -6.905 -7.644 -6.105 -5.541 -8.076 -5.004
Free Cash Flow 1 -120.7 -220.3 -461.8 20.76 -474.6 106
FCF margin -12.58% -12.34% -11.69% 0.25% -3.82% 0.78%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 5/17/18 4/10/19 4/16/20 4/30/21 4/29/22 4/28/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 461 1,107 373 1,160 306 385
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -121 -220 -462 20.8 -475 106
ROE (net income / shareholders' equity) -37.4% -42.8% -50.2% -44.4% -57% -50.2%
ROA (Net income/ Total Assets) -18.6% -21.7% -19.5% -12.8% -13% -7.01%
Assets 1 1,335 1,754 2,557 3,578 5,151 5,951
Book Value Per Share 2 -26.30 15.00 9.460 4.320 -2.090 -4.960
Cash Flow per Share 2 4.660 10.50 7.080 14.40 7.960 8.070
Capex 1 6.8 14.4 20 25.5 62.6 31.6
Capex / Sales 0.71% 0.81% 0.51% 0.31% 0.5% 0.23%
Announcement Date 5/17/18 4/10/19 4/16/20 4/30/21 4/29/22 4/28/23
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
111, INC. Stock 111, Inc.
-33.55% 86.51M
MCKESSON CORPORATION Stock McKesson Corporation
+17.35% 71.39B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+5.38% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+6.69% 8.19B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.96% 7.91B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+0.49% 4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.31B
EBOS GROUP LIMITED Stock EBOS Group Limited
-3.38% 3.93B
GALENICA AG Stock Galenica AG
-2.61% 3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+22.08% 3.64B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. YI Stock
  4. Financials 111, Inc.